Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

1.07 (USD) • At close May 1, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 1.0280002.750000000-2.71701.9610.7560.210.1080.060.083
Kosten van de omzet 0.26600.2550.2480.2270.4780.44900.410.3520.2820.2680.1130.12000000
Brutowinst 0.7620-0.255-0.2482.523-0.478-0.4490-0.41-0.352-0.282-0.268-2.83-0.121.9610.7560.210.1080.060.083
Brutowinstmarge 0.7410000.917000000000111111
Onderzoek- en ontwikkelingskosten 6.816.1726.1157.5867.60611.2211.0869.71210.3869.1039.5287.5917.41711.9593.7593.3473.3362.092.5584.06
Algemene en administratieve kosten 5.4625.6276.4096.4485.8286.6357.2086.8047.0977.2396.3196.1895.94515.8223.462.6071.8180.8450.8921.407
Verkoop- en marketingkosten 000-0.248-0.227000000000000000
Verkoop-, algemene en administratieve kosten 5.4625.6276.4096.25.6016.6357.2086.8047.0977.2396.3196.1895.94515.8223.462.6071.8180.8450.8921.407
Overige kosten 3.7140000000000000000000
Bedrijfskosten 15.98611.79912.52413.78613.20717.85518.29416.51617.48316.34215.84713.7813.36227.7817.2195.9545.1542.9353.455.467
Bedrijfsresultaat -14.958-11.799-12.524-14.034-13.434-17.855-18.294-16.516-17.483-16.342-15.847-13.785.771-27.781-5.258-5.198-4.944-2.827-3.39-5.384
Bedrijfsresultaat ratio -14.551000-4.885000000000-2.681-6.876-23.543-26.176-56.5-64.867
Totaal overige inkomsten en kosten netto -0.764-0.923-0.837-0.745-0.621-0.477-0.37-0.3160.0990.0270.0350.0150.017-0.882-0.226-0.357-0.8-0.0510.6820.045
Inkomen voor belasting -15.722-12.722-13.361-14.779-14.055-18.332-18.664-16.832-17.384-16.315-15.812-13.765-13.345-28.663-5.484-5.555-5.744-2.878-2.708-5.339
Inkomen voor belasting ratio -15.294000-5.111000000000-2.797-7.348-27.352-26.648-45.133-64.325
Belastingkosten 000-7.296-6.957-9.135-9.3610-0.041-0.1070.1540.063-0.1220.0370.0010.0430.0120.0050.0060.011
Nettowinst -8.947-6.783-6.805-7.483-7.098-9.197-9.303-8.372-17.343-16.208-15.966-13.828-13.223-3.142-5.485-5.598-16.703-2.883-2.714-5.35
Nettowinstmarge -8.703000-2.581000000000-2.797-7.405-79.538-26.694-45.233-64.458
WPA (Winst Per Aandeel) -0.27-0.24-0.26-0.29-0.27-0.36-0.37-0.33-0.7-0.66-0.66-0.65-0.68-0.16-0-0.3-0.89-0.15-0.14-0.29
Verwaterde WPA -0.27-0.24-0.26-0.29-0.27-0.36-0.37-0.33-0.7-0.66-0.66-0.65-0.68-0.16-0-0.3-0.89-0.15-0.14-0.29
EBITDA -14.332-11.126-11.83-13.237-12.532-16.538-16.949-15.437-16.254-15.611-15.69-13.654-13.233-28.433-5.187-5.231-5.544-2.67-2.556-5.186
EBITDA ratio -13.942000-4.557000000000-2.645-6.919-26.4-24.722-42.6-62.482